Insys executives are guilty of paying doctors to boost sales of a painkiller meant for cancer patients – actions some say are at least partially for the country’s current opioid crisis – a jury determined Thursday afternoon.
Insys executives are guilty of paying doctors to boost sales of a painkiller meant for cancer patients – actions some say are at least partially for the country’s current opioid crisis – a jury determined Thursday afternoon.